Page last updated: 2024-09-03

pak 104p and epirubicin

pak 104p has been researched along with epirubicin in 1 studies

Compound Research Comparison

Studies
(pak 104p)
Trials
(pak 104p)
Recent Studies (post-2010)
(pak 104p)
Studies
(epirubicin)
Trials
(epirubicin)
Recent Studies (post-2010) (epirubicin)
16005,4531,8381,570

Protein Interaction Comparison

ProteinTaxonomypak 104p (IC50)epirubicin (IC50)
Genome polyprotein 0.75
Tyrosine-protein kinase FynHomo sapiens (human)5.181

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garnier-Suillerot, A; Marbeuf-Gueye, C; Quidu, P; Salerno, M1

Other Studies

1 other study(ies) available for pak 104p and epirubicin

ArticleYear
Inhibition of the P-glycoprotein- and multidrug resistance protein-mediated efflux of anthracyclines and calceinacetoxymethyl ester by PAK-104P.
    European journal of pharmacology, 2000, Mar-17, Volume: 391, Issue:3

    Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cyclic P-Oxides; Daunorubicin; Depression, Chemical; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epirubicin; Fluoresceins; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Nicotinic Acids; Tumor Cells, Cultured

2000